Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Integrin beta-7 antagonist PubMed
Primary Target
integrin α4β7

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Colitis, Ulcerative 3 D003093 ClinicalTrials
Crohn Disease 3 D003424 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1044758-60-2
ChEMBL CHEMBL1743015
FDA SRS I2A72G2V3J
Guide to Pharmacology 8407